SMTA/CIR/May/2026
Revised Regulatory Guidelines For Sampling Of Drugs, Cosmetics Medical Devices By Drugs Inspectors Of Central State Drug Authorities
In order to streamline and rationalize the sampling procedure of drugs, cosmetics & medical devices and maintaining a centralized monthly database of NSQ/Spurious drugs to publish on CDSCO Website, draft regulatory guidelines for sampling of drugs, cosmetics & medical devices by Drugs Inspectors of Central & State Drug Authorities was circulated to all zonal/sub zonal offices of CDSCO and State Licensing Authorities for their inputs and suggestions.
In this regard, the inputs/suggestions were received and has been incorporated appropriately in the guidance document. Copy of final guidance document is enclosed herewith for necessary implementation by Central & State Drug Authorities.
 |
Click here to view details |
